Search results
Results from the WOW.Com Content Network
Sudden weight gain can be an early symptom of heart failure, according to the American Heart Association. Weight gain of more than two or three pounds within a 24 hour period may be a sign your ...
A second major cause is an age-related decline in stomach acid production (achlorhydria), because acid exposure frees protein-bound vitamin. [12] For the same reason, people on long-term antacid therapy, using proton-pump inhibitors , [ 13 ] H 2 blockers or other antacids are at increased risk.
Its deficiency can cause neurodevelopmental problems which can be partly reversible with early treatment. [27] Only a small subset of dementia cases have been found to be reversible with vitamin B 12 therapy. [28] Tinnitus may be associated with vitamin B 12 deficiency. [29] Vitamin B 12 deficiency may accompany certain eating disorders or ...
“Pregnant women and women trying to conceive should be taking prenatal vitamins. The most important reason is the folate supplementation,” says s Shanna Levine, M.D. , primary care physician ...
Atrophic gastritis can also cause intrinsic factor deficiency and anemia through damage to the parietal cells of the stomach wall. [16] Pancreatic exocrine insufficiency can interfere with normal dissociation of vitamin B 12 from its binding proteins in the small intestine, preventing its absorption via the intrinsic factor complex. [ 17 ]
Anorexia is the leading cause of significant weight loss in young women and is the primary reason for their admission to child and adolescent hospital services. [130] In most cases, a clear diagnosis of weight loss driven by psychological factors can be made without resorting to a series of complex tests.
Berberine can upset your gastrointestinal system, causing symptoms like: nausea, diarrhea, constipation, gas and abdominal pain, Simmons says. It’s also possible that taking berberine can ...
Thiazolidinediones may cause slight weight gain but decrease "pathologic" abdominal fat (visceral fat), and therefore may be prescribed for diabetics with central obesity. [115] Thiazolidinedione has been associated with heart failure and increased cardiovascular risk; so it has been withdrawn from the market in Europe by EMA in 2010. [116]